Sort
15,842 grants matching “pancreatic cancer”
Surrogate biomarkers for assessing changes in pancreatic cancer tumor microenvironment
$609,088Marvin M Doyley · University Of Rochester · R01 · FY2022 · EB
The Role of Carboxypeptidase E in Cancer
$609,044Yoke P Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus
$608,641Alvin Carter Powers · Vanderbilt University Medical Center · R24 · FY2015 · DK
High-Performance High-Field Parallel MRI.
$608,553Daniel K Sodickson · New York University School Of Medicine · R01 · FY2014 · EB
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
$608,525Shengyu Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · CA
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma
$608,037Christopher A Klug · University Of Alabama At Birmingham · P50 · FY2012 · CA
HIFU-immunotherapy in pancreatic cancer
$608,025Katherine W Ferrara · Stanford University · R01 · FY2023 · CA
Large scale clinical and economic impact analysis of potentially malignant incidental findings in radiology reports
$607,882Meliha Yetisgen · University Of Washington · R01 · FY2024 · CA
INVESTIGATING THE ROLE OF PIEZO1 IN PANCREATIC CANCER-RELATED IMMUNE SUPPRESSION AND DISEASE PROGRESSION
$607,538New York University · · FY2018 · Department of the Army
Penn Quantitative MRI Resource for Pancreatic Cancer
$607,181Rong Zhou · University Of Pennsylvania · U24 · FY2021 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer
$607,181Rong Zhou · University Of Pennsylvania · U24 · FY2020 · CA
Targeting RAS in Pediatric Cancer
$607,140Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$607,124Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2022 · CA
Development of contrast agents to facilitate image-guided surgery
$607,029Lacey R McNally · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
$606,614James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The CCK-B receptor signaling pathway as a driver of pancreatic cellular plasticity and carcinogenesis
$606,404Jill P Smith · Georgetown University · R01 · FY2023 · CA
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
$606,372Huang Chiao Huang · Univ Of Maryland, College Park · R01 · FY2024 · CA
Developing a Translation Pipeline for VHL Mutant Malignancies
$606,369David McDermott · Beth Israel Deaconess Medical Center · U01 · FY2025 · CA
Clinical Trials with Immunotoxins
$606,310Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Early Diagnosis of Pancreatic Cancer
$606,189Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2011 · CA
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol
$606,121Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
Biomolecular Recognition and Binding Mechanisms
$606,037Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Stromal targeting to improve the efficacy of systemically administered drugs for pancreatic ductal adenocarcinomas
$605,990Luis Solorio · Purdue University · R01 · FY2025 · CA
F-18 Labeled Peptides for Pretargeted PET Imaging of Pancreatic Cancer
$605,718William John McBride · Immunomedics, Inc. · R44 · FY2009 · RR
A multimodal imaging system and targeted nanoprobes for image-guided treatment of breast cancer
$605,704Huabei Jiang · University Of South Florida · R01 · FY2017 · EB